Depression can have a real impact on quality of life. But right now, treatments for depression in Parkinson’s Disease (PD) are inadequate. Researchers at Yale University are investigating whether a course of ketamine treatment will result in a significant reduction in depression severity.

Findings from this clinical research study will determine if ketamine can reduce depression and possibly target other symptoms of PD. 

The trial will involve receiving either ketamine or placebo twice per week for three weeks. You will also have the option to take part in brain imaging before and after the treatment.

Further research today and join our compensated study!